Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/09/23 | 24/09/25 | 763,359 sh | $1.84 | $1,404,580.56 | +26.4% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/07/11 | 24/07/15 | 5,000 sh | $7.48 | $37,400 | +4.1% |
David JinCFO | Fortress BiotechFBIO | Open-market buy | 24/07/10 | 24/07/12 | 500 sh | $7.50 | $3,750 | No record |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/07/09 | 24/07/11 | 5,000 sh | $7.39 | $36,950 | +4.3% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/07/08 | 24/07/10 | 5,000 sh | $7.35 | $36,750 | +4.4% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/06/28 | 24/07/01 | 20,000 sh | $1.64 | $32,800 | +0.7% |
Dov KleinDirector | Fortress BiotechFBIO | Open-market sale | 24/05/20 | 24/05/20 | 10,000 sh | $1.89 | $18,900 | −15.8% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/05/16 | 24/05/20 | 10,000 sh | $1.76 | $17,600 | +0.3% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 24/01/05 | 24/01/09 | 50,000 sh | $2.38 | $119,000 | +1.8% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 23/11/14 | 23/11/16 | 1,567,515 sh | $1.70 | $2,664,775.5 | +152.2% |
Michael S. WeissSEE REMARKS | Fortress BiotechFBIO | Open-market buy | 23/11/14 | 23/11/16 | 147,058 sh | $1.70 | $249,998.6 | +15.0% |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 23/09/26 | 23/09/27 | 100,000 sh | $0.28 | $28,000 | +0.7% |
Fortress BiotechFBIO | Open-market buy | 23/08/17–23/08/18 | 23/08/21 | 20,000 sh2 trades | $10.55avg. | $210,900 | +21.6% | |
Lindsay A. Md RosenwaldPresident, CEO & Chairman | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 2,395,209 sh | $0.84 | $2,011,975.56 | +18.5% |
Michael S. WeissSEE REMARKS | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 1,197,604 sh | $0.84 | $1,005,987.36 | +8.8% |
J. Jay LobellDirector | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 299,401 sh | $0.84 | $251,496.84 | +22.4% |
Eric K. RowinskyDirector | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 11,976 sh | $0.84 | $10,059.84 | +1.3% |
Lucy LuDirector | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 11,976 sh | $0.84 | $10,059.84 | +9.9% |
David JinCFO | Fortress BiotechFBIO | Open-market buy | 23/02/10 | 23/02/14 | 35,928 sh | $0.84 | $30,179.52 | +2.6% |
